Dr. Martin Kaiser on High-Risk Multiple Myeloma & Personalized Treatment
Автор: MD Newsline
Загружено: 2025-06-16
Просмотров: 13
In this insightful conversation, Dr. Martin Kaiser shares critical updates on the evolving approach to treating high-risk multiple myeloma, offering expert insight into how personalized myeloma treatment is reshaping patient care.
He explains what is multiple myeloma cancer, how genomic testing is helping to identify high-risk profiles, and the role of MRD monitoring (minimal residual disease) in tracking response to therapy. Whether you're newly diagnosed or supporting a loved one, this video provides a comprehensive view of multiple myeloma explained in a clinical yet accessible way.
💬 Topics covered:
🔬 What is multiple myeloma, and how is it different from other cancers
🧬 How genomic testing is used to guide multiple myeloma treatment
💉 The rise of CAR T cell therapy and bispecific antibodies multiple myeloma research
🧠 Understanding myeloma physical therapy and multiple myeloma physical therapy approaches
🔍 How MRD monitoring is changing the way doctors track multiple myeloma cancer progression
This is a must-watch for anyone interested in the latest science behind myeloma, future treatment options, and the ongoing search for a multiple myeloma cure.
#multiplemyeloma #myelomacancer #highriskmultiplemyeloma #carTcelltherapy #genomictesting #personalizedtreatment #MRDmonitoring #cancerresearch #myelomatreatment #myelomaphysicaltherapy

Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: